2nd Abu Dhabi Brain Conference 2022 Program Book

TUNE THE FREQUENCY MIGRAINE DAYS TAKE CONTROL OF BOTOX ® reduces headache days in patients with chronic migraine progressively for up to 3 treatment cycles with 71% response rate 1 AbbVie Biopharmaceuticals GmbH Suite 2901, UBora Tower POBox: 118052 Business Bay, Dubai, UAE OFFICE : +971 45506100 - FAX: +971 45506101 For Adverse Events Reporting: Email: PV.MEA@abbvie.com Hot line number: +971 56 413 5746 +965 22 052 024 All rights reserved. This material is protected by Copyrights and other intellectual property protection laws.” AE-BTX-220001 1. Silberstein, S.D. et al., 2014. Per cent of patients with chronic migraine who responded per ONABOTULINUMTOXINA treatment cycle: Preempt. Journal of Neurology, Neurosurgery & Psychiatry, 86(9), pp.996–1001.